Extension Study of Gelesis100 on Body Weight
Public ClinicalTrials.gov record NCT03021291. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label Study Assessing the Effect of Gelesis100 on Weight Loss and Weight Maintenance in Overweight and Obese Subjects Who Completed the GLOW Study (G-04)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to assess the effect of Gelesis100 on body weight after an additional exposure of 24 weeks in subjects who completed the 24-week treatment period, and had at least 3% weight loss, in the Gelesis Loss Of Weight GLOW, NCT02307279) study.
Study identification
- NCT ID
- NCT03021291
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 36 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 25, 2017 (Actual)
- Primary completion
- Dec 8, 2017 (Actual)
- Completion
- Dec 15, 2017 (Actual)
- Last update posted
- Feb 22, 2018
2017
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arternis Institute for Clinical Research | San Diego | California | 92103 | — |
| Clinical Trial Investigators | Tustin | California | 92780 | — |
| University of Colorado | Aurora | Colorado | 80045 | — |
| Westside Center for Clinical Research | Jacksonville | Florida | 32205 | — |
| Pennington Biomedical Research | Baton Rouge | Louisiana | 70808 | — |
| Boston University Medical Center | Boston | Massachusetts | 02118 | — |
| Cornell Weill Medical College | New York | New York | 10065 | — |
| Radiant Research | Cincinnati | Ohio | 45249 | — |
| Aventiv Research | Columbus | Ohio | 43213 | — |
| Geisinger Health System | Danville | Pennsylvania | 17822 | — |
| Texas Diabetes and Endocrinology | Round Rock | Texas | 78681 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03021291, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 22, 2018 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03021291 live on ClinicalTrials.gov.